iX Biopharma IPO draws strong response, opens 7.6% higher in Catalist debut

iX Biopharma IPO draws strong response, opens 7.6% higher in Catalist debut

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter